Jiraporn Tocharus Selected Research

nonivamide

7/2020	Capsaicinoid nonivamide improves nonalcoholic fatty liver disease in rats fed a high-fat diet.
7/2019	Synergistic effects of the capsaicinoid nonivamide and rosuvastatin on obesity-related endothelial dysfunction in rat fed a high-fat diet.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jiraporn Tocharus Research Topics

Disease

14	Inflammation (Inflammations) 01/2022 - 05/2010
11	Brain Ischemia (Cerebral Ischemia) 11/2022 - 01/2017
8	Infarction (Infarctions) 02/2022 - 01/2017
7	Alzheimer Disease (Alzheimer's Disease) 04/2021 - 01/2016
6	Reperfusion Injury 11/2022 - 01/2017
5	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 02/2022 - 01/2020
5	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 04/2014
5	Neuroblastoma 01/2021 - 01/2015
4	Cognitive Dysfunction 01/2022 - 01/2020
4	Atherosclerosis 08/2021 - 03/2016
3	Neuroinflammatory Diseases 01/2022 - 07/2015
3	Glioma (Gliomas) 01/2017 - 04/2014
2	Ischemia 11/2022 - 01/2020
2	Gliosis 01/2022 - 03/2020
2	Hypertension (High Blood Pressure) 01/2022 - 12/2019
2	Cardiovascular Diseases (Cardiovascular Disease) 08/2021 - 10/2016
2	Obesity 01/2021 - 07/2019
2	Ischemic Stroke 01/2021 - 01/2017
2	Insulin Resistance 07/2020 - 07/2019
2	Body Weight (Weight, Body) 05/2020 - 12/2019
2	Amyloid Plaque 01/2016 - 01/2015
2	Colonic Neoplasms (Colon Cancer) 12/2012 - 05/2012
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2022
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2022
1	Vascular Remodeling 01/2022
1	Brain Injuries (Brain Injury) 01/2022
1	Necrosis 12/2021
1	Wounds and Injuries (Trauma) 12/2021
1	Brain Infarction 10/2021
1	Hyperlipidemias (Hyperlipidemia) 08/2021
1	Non-alcoholic Fatty Liver Disease 07/2020
1	Hypoxia (Hypoxemia) 05/2020
1	Cerebral Infarction 01/2020

Drug/Important Bio-Agent (IBA)

9	MelatoninIBA 01/2022 - 04/2014
8	AntioxidantsIBA 01/2022 - 07/2015
5	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 05/2010
5	Proteins (Proteins, Gene)FDA Link 01/2022 - 09/2005
5	hexahydrocurcuminIBA 01/2022 - 05/2012
5	Amyloid (Amyloid Fibrils)IBA 04/2021 - 01/2015
4	agomelatine (S20098)IBA 02/2022 - 01/2017
4	Neuroprotective AgentsIBA 01/2022 - 09/2018
4	Methamphetamine (Desoxyn)FDA LinkGeneric 01/2017 - 04/2014
3	CollagenIBA 01/2022 - 09/2005
3	dihydrocapsaicinIBA 10/2021 - 01/2017
3	cyanidinIBA 09/2018 - 12/2014
2	morinIBA 02/2022 - 01/2020
2	Cholinergic Agents (Cholinergics)IBA 01/2022 - 04/2021
2	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 01/2022 - 01/2017
2	CurcuminIBA 01/2022 - 06/2020
2	NG-Nitroarginine Methyl Ester (L-NAME)IBA 01/2022 - 12/2019
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2021 - 01/2017
2	CytokinesIBA 12/2021 - 03/2020
2	Caspase 3 (Caspase-3)IBA 10/2021 - 01/2017
2	Dexamethasone (Maxidex)FDA LinkGeneric 04/2021 - 01/2020
2	Amyloid beta-PeptidesIBA 01/2021 - 07/2018
2	GlucocorticoidsIBA 12/2020 - 01/2020
2	nonivamideIBA 07/2020 - 07/2019
2	Evans Blue (Blue, Evans)FDA Link 06/2020 - 01/2017
2	Pharmaceutical PreparationsIBA 12/2019 - 04/2014
2	Peptides (Polypeptides)IBA 07/2018 - 01/2016
2	cyanidin-3-O-beta-glucopyranosideIBA 10/2016 - 03/2016
2	Angiotensin IIIBA 10/2016 - 03/2016
2	Atorvastatin (Lipitor)FDA Link 09/2016 - 03/2016
2	DiarylheptanoidsIBA 01/2016 - 09/2015
2	demethylcurcuminIBA 01/2016 - 01/2015
2	Fluorouracil (Carac)FDA LinkGeneric 12/2012 - 05/2012
1	HMGB1 Protein (HMG1)IBA 11/2022
1	CateninsIBA 02/2022
1	flavan-3-olIBA 01/2022
1	Galactose (Galactopyranose)FDA LinkGeneric 01/2022
1	Aluminum ChlorideIBA 01/2022
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2022
1	Advanced Glycation End ProductsIBA 01/2022
1	Malondialdehyde (Propanedial)IBA 01/2022
1	arginine methyl esterIBA 01/2022
1	Antihypertensive Agents (Antihypertensives)IBA 01/2022
1	Biological ProductsIBA 01/2022
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 12/2021
1	Interleukin-1 (Interleukin 1)IBA 12/2021
1	neferineIBA 12/2021
1	Nimodipine (Modus)FDA LinkGeneric 12/2021
1	CalciumIBA 12/2021
1	InflammasomesIBA 08/2021
1	oxidized low density lipoproteinIBA 08/2021
1	tau Proteins (tau Protein)IBA 04/2021
1	LipidsIBA 07/2020
1	Immunoglobulin G (IgG)IBA 06/2020
1	triphenyltetrazoliumIBA 05/2020
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 05/2020
1	Angiogenesis InhibitorsIBA 05/2020
1	Metalloproteases (Metalloproteinases)IBA 05/2020
1	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 05/2020
1	salicylhydroxamic acid (SHAM)IBA 05/2020
1	Angiopoietin-1IBA 05/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2020
1	Interleukin-6 (Interleukin 6)IBA 03/2020
1	IntegrinsIBA 03/2020
1	NF-kappa B (NF-kB)IBA 03/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2020

Therapy/Procedure

3	Therapeutics 07/2019 - 04/2012